TipRanks
Go Ultimate55% OFF

Kevin Sayer Insider Profile

4 Followers

Kevin Sayer, Executive Chair, Director at Dexcom, holds 302.21K shares in Dexcom (Ticker: DXCM).

Kevin Sayer's Trading History

DXCM
Dexcom
Aug 24, 2026Executive Chair, DirectorUninformative Sell2.41M$24.87M
DXCM
Insider Shares: 302.21K (0.08%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 24, 2026Uninformative Sell$2.41M26,756$90.00―
Jul 21, 2026Uninformative Sell$2.04M26,756$76.31―
Jul 07, 2026Uninformative Sell$1.93M26,756$72.00―
May 26, 2026Uninformative Sell$1.93M26,759$72.00―
Mar 10, 2026Uninformative Sell$2.21M32,498$68.10―

You May Also Like

Kevin Sayer insider profile FAQ

What is the percentage of profitable transactions made by Kevin Sayer?
The percentage of profitable transactions made by Kevin Sayer is 60%.
What is the average return per transaction made by Kevin Sayer?
The average return per transaction made by Kevin Sayer is -28.40%.
What stocks does Kevin Sayer hold?
Kevin Sayer holds: DXCM stocks.
What was Kevin Sayer’s latest transaction?
Kevin Sayer’s latest transaction was an Uninformative Sell of $2.41M.
What was Kevin Sayer's most profitable transaction?
Kevin Sayer’s most profitable transaction was an Informative Sell of DXCM stock on August 11, 2016. The return on the trade was 23.40%.
What is Kevin Sayer's role in Dexcom?
Kevin Sayer's role in Dexcom is Executive Chair, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.